Literature DB >> 26320740

Plasma phospholipid transfer protein (PLTP) modulates adaptive immune functions through alternation of T helper cell polarization.

Catherine Desrumaux1,2,3, Stéphanie Lemaire-Ewing1,2,3,4, Nicolas Ogier1,2,3, Akadiri Yessoufou1,2,3, Arlette Hammann1,3,4, Anabelle Sequeira-Le Grand2,5, Valérie Deckert1,2,3, Jean-Paul Pais de Barros1,2,3, Naïg Le Guern1,2,3, Julien Guy4, Naim A Khan1,2,3, Laurent Lagrost1,2,3,4.   

Abstract

OBJECTIVE: Plasma phospholipid transfer protein (PLTP) is a key determinant of lipoprotein metabolism, and both animal and human studies converge to indicate that PLTP promotes atherogenesis and its thromboembolic complications. Moreover, it has recently been reported that PLTP modulates inflammation and immune responses. Although earlier studies from our group demonstrated that PLTP can modify macrophage activation, the implication of PLTP in the modulation of T-cell-mediated immune responses has never been investigated and was therefore addressed in the present study. Approach and results: In the present study, we demonstrated that PLTP deficiency in mice has a profound effect on CD4+ Th0 cell polarization, with a shift towards the anti-inflammatory Th2 phenotype under both normal and pathological conditions. In a model of contact hypersensitivity, a significantly impaired response to skin sensitization with the hapten-2,4-dinitrofluorobenzene (DNFB) was observed in PLTP-deficient mice compared to wild-type (WT) mice. Interestingly, PLTP deficiency in mice exerted no effect on the counts of total white blood cells, lymphocytes, granulocytes, or monocytes in the peripheral blood. Moreover, PLTP deficiency did not modify the amounts of CD4+ and CD8+ T lymphocyte subsets. However, PLTP-deficiency, associated with upregulation of the Th2 phenotype, was accompanied by a significant decrease in the production of the pro-Th1 cytokine interleukin 18 by accessory cells.
CONCLUSIONS: For the first time, this work reports a physiological role for PLTP in the polarization of CD4+ T cells toward the pro-inflammatory Th1 phenotype.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26320740      PMCID: PMC5101448          DOI: 10.1038/cmi.2015.75

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  55 in total

1.  Increased circulating interleukin-18 in patients with congestive heart failure.

Authors:  Y Naito; T Tsujino; Y Fujioka; M Ohyanagi; H Okamura; T Iwasaki
Journal:  Heart       Date:  2002-09       Impact factor: 5.994

Review 2.  Interleukin-18 is a unique cytokine that stimulates both Th1 and Th2 responses depending on its cytokine milieu.

Authors:  K Nakanishi; T Yoshimoto; H Tsutsui; H Okamura
Journal:  Cytokine Growth Factor Rev       Date:  2001-03       Impact factor: 7.638

3.  Membrane microdomain organization, calcium signal, and NFAT activation as an important axis in polarized Th cell function.

Authors:  Emese Izsepi; Leonora Himer; Orsolya Szilagyi; Peter Hajdu; György Panyi; Gloria Laszlo; Janos Matko
Journal:  Cytometry A       Date:  2012-11-26       Impact factor: 4.355

4.  Phospholipid transfer protein activity is associated with inflammatory markers in patients with cardiovascular disease.

Authors:  Marian C Cheung; B Greg Brown; Emily K Marino Larsen; Andrew D Frutkin; Kevin D O'Brien; John J Albers
Journal:  Biochim Biophys Acta       Date:  2005-09-21

5.  ApoE-containing high density lipoproteins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response.

Authors:  S Barlage; D Fröhlich; A Böttcher; M Jauhiainen; H P Müller; F Noetzel; G Rothe; C Schütt; R P Linke; K J Lackner; C Ehnholm; G Schmitz
Journal:  J Lipid Res       Date:  2001-02       Impact factor: 5.922

6.  Overexpression of IL-18 decreases intimal collagen content and promotes a vulnerable plaque phenotype in apolipoprotein-E-deficient mice.

Authors:  R de Nooijer; J H von der Thüsen; C J N Verkleij; J Kuiper; J W Jukema; E E van der Wall; J C van Berkel; E A L Biessen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-10-07       Impact factor: 8.311

Review 7.  The biology of IL-12: coordinating innate and adaptive immune responses.

Authors:  Wendy T Watford; Masato Moriguchi; Akio Morinobu; John J O'Shea
Journal:  Cytokine Growth Factor Rev       Date:  2003-10       Impact factor: 7.638

8.  Diacylglycerol kinase α establishes T cell polarity by shaping diacylglycerol accumulation at the immunological synapse.

Authors:  Anne Chauveau; Audrey Le Floc'h; Niels S Bantilan; Gary A Koretzky; Morgan Huse
Journal:  Sci Signal       Date:  2014-08-26       Impact factor: 8.192

Review 9.  Plasma phospholipid transfer protein (PLTP): review of an emerging cardiometabolic risk factor.

Authors:  T Tzotzas; C Desrumaux; L Lagrost
Journal:  Obes Rev       Date:  2009-04-21       Impact factor: 9.213

10.  Circulating interleukin-18: A specific biomarker for atherosclerosis-prone patients with metabolic syndrome.

Authors:  Minako Yamaoka-Tojo; Taiki Tojo; Kazuki Wakaume; Ryo Kameda; Shinji Nemoto; Naonobu Takahira; Takashi Masuda; Tohru Izumi
Journal:  Nutr Metab (Lond)       Date:  2011-01-20       Impact factor: 4.169

View more
  9 in total

Review 1.  Impact of Phospholipid Transfer Protein in Lipid Metabolism and Cardiovascular Diseases.

Authors:  Xian-Cheng Jiang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Plasma phospholipid transfer protein (PLTP) as an emerging determinant of the adaptive immune response.

Authors:  Catherine Desrumaux; Laurent Lagrost
Journal:  Cell Mol Immunol       Date:  2018-05-07       Impact factor: 11.530

Review 3.  Phospholipid transfer protein: its impact on lipoprotein homeostasis and atherosclerosis.

Authors:  Xian-Cheng Jiang
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

Review 4.  The Role of Phospholipid Transfer Protein in the Development of Atherosclerosis.

Authors:  Xian-Cheng Jiang; Yang Yu
Journal:  Curr Atheroscler Rep       Date:  2021-01-26       Impact factor: 5.113

5.  Enhanced Proliferation of Ly6C+ Monocytes/Macrophages Contributes to Chronic Inflammation in Skin Wounds of Diabetic Mice.

Authors:  Jingbo Pang; Mark Maienschein-Cline; Timothy J Koh
Journal:  J Immunol       Date:  2020-12-21       Impact factor: 5.422

6.  PhosphoLipid transfer protein (PLTP) exerts a direct pro-inflammatory effect on rheumatoid arthritis (RA) fibroblasts-like-synoviocytes (FLS) independently of its lipid transfer activity.

Authors:  Rachel Audo; Valérie Deckert; Claire I Daien; Hélène Che; Jamila Elhmioui; Stéphanie Lemaire; Jean-Paul Pais de Barros; Catherine Desrumaux; Bernard Combe; Michael Hahne; Laurent Lagrost; Jacques Morel
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

7.  Deletion of plasma Phospholipid Transfer Protein (PLTP) increases microglial phagocytosis and reduces cerebral amyloid-β deposition in the J20 mouse model of Alzheimer's disease.

Authors:  Marine Mansuy; Stella Baille; Geoffrey Canet; Amélie Borie; Catherine Cohen-Solal; Michel Vignes; Véronique Perrier; Nathalie Chevallier; Naig Le Guern; Valérie Deckert; Laurent Lagrost; Laurent Givalois; Catherine Desrumaux
Journal:  Oncotarget       Date:  2018-04-13

8.  The serum of COVID-19 asymptomatic patients up-regulates proteins related to endothelial dysfunction and viral response in circulating angiogenic cells ex-vivo.

Authors:  Rafael Moreno-Luna; Mª Carmen Durán-Ruiz; Lucía Beltrán-Camacho; Sara Eslava-Alcón; Marta Rojas-Torres; Daniel Sánchez-Morillo; Mª Pilar Martinez-Nicolás; Victoria Martín-Bermejo; Inés García de la Torre; Esther Berrocoso; Juan Antonio Moreno
Journal:  Mol Med       Date:  2022-04-09       Impact factor: 6.354

9.  Plasma cholesterol level determines in vivo prion propagation.

Authors:  Véronique Perrier; Thibaud Imberdis; Pierre-André Lafon; Marina Cefis; Yunyun Wang; Elisabeth Huetter; Jacques-Damien Arnaud; Teresa Alvarez-Martinez; Naig Le Guern; Guillaume Maquart; Laurent Lagrost; Catherine Desrumaux
Journal:  J Lipid Res       Date:  2017-08-01       Impact factor: 5.922

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.